Tri Locum Partners’s Insmed INSM Stock Holding History

Tri Locum Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-101,859	Closed	-$7.77M	–	28
2025 Q1	$7.77M	Buy	+101,859	New	+$7.79M	3.99%	11
2024 Q4	–	Sell	-143,920	Closed	-$10.5M	–	29
2024 Q3	$10.5M	Sell	143,920 -172,581	-55%	-$12.7M	2.52%	12
2024 Q2	$21.2M	Buy	+316,501	New	+$12.3M	5.36%	7

Other funds holding INSM

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Tri Locum Partners's INSM Position: Q2 2025 in Review

Tri Locum Partners sold out of Insmed (INSM) in Q2 2025, closing a stake of 101,859 shares — an estimated $7.77M sold.

Tri Locum Partners first reported a position in INSM in Q2 2024 and held it in 3 quarters. The position peaked at $21.2M in Q2 2024. 516 funds tracked by Wall St. Rank hold INSM as of Q2 2025.

Tri Locum Partners reported no remaining Insmed position as of Q2 2025 after selling out during the quarter.
Tri Locum Partners sold 101,859 Insmed shares in Q2 2025, an estimated $7.77M.
Tri Locum Partners first reported a position in Insmed in Q2 2024 and held it in 3 quarters.
Tri Locum Partners's Insmed position peaked at $21.2M in Q2 2024.
516 funds tracked by Wall St. Rank held Insmed as of Q2 2025.

Based on Tri Locum Partners's 13F filing for Q2 2025, filed 14 Aug 2025.